BH3:FRA
PTC Therapeutics, Inc.
€57.44
arrow_downward
-1.95%(-1.14) 1H
9 Nov, 10:00:00 PTG GMT+1 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk BH3...
Buka
€57.58
Tinggi
€57.58
Rendah
€56.86
Permodalan Pasaran
5.43B
Volum
0.00
tgi 52 mgu
€77.02
rdh 52 mgu
€51.64
Bilangan pekerja
991
Buka
€57.58
Tinggi
€57.58
Rendah
€56.86
Permodalan Pasaran
5.43B
Volum
0.00
tgi 52 mgu
€77.02
rdh 52 mgu
€51.64
Bilangan pekerja
991
Cerita berita
Daripada sumber web dan rakan kongsi berita
Yahoo! Finance Canada
·
3 hari lalu
PTC Therapeutics, Inc. (PTCT) Seasonal Returns Chart - Yahoo Finance
Profil
PTC Therapeutics, Inc. is an U.S.-based pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapies that alter gene expression via post-transcriptional control mechanisms in orphan diseases.
In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
Perihal PTC Therapeutics, Inc.
CEOMatthew B. Klein
Pekerja991
Diasaskan1 Jan 1998
Ibu pejabatWarren, New Jersey, Amerika Syarikat
SektorHealth Care
Industri-
Laman webptcbio.com